Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Rhea-AI Summary

Elutia (Nasdaq: ELUT), a pioneer in drug-eluting biomatrix technologies, has scheduled the release of its fourth quarter and full year 2024 financial results for Thursday, March 6, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. Management will be available for discussion during the call, which can be accessed through U.S. (877-407-8029) and International (201-689-8029) dial-in numbers using Conference ID 13751810. A live and archived webcast will be available on the company's investor relations website.

News Market Reaction – ELUT

+0.63%

+0.63% Session move

In the trading session that priced this news, ELUT gained 0.63%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SILVER SPRING, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13751810

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at http://investors.elutia.com/.

About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com

FAQ

When will Elutia (ELUT) release Q4 and full year 2024 earnings?

Elutia will release its Q4 and full year 2024 financial results after market close on Thursday, March 6, 2025.

What time is Elutia's (ELUT) Q4 2024 earnings call?

Elutia's Q4 2024 earnings conference call is scheduled for 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on March 6, 2025.

How can investors access Elutia's (ELUT) Q4 2024 earnings call?

Investors can access the call through U.S. dial-in (877-407-8029), International dial-in (201-689-8029), Conference ID 13751810, or via webcast on the company's investor relations website.

Where can I find the webcast of Elutia's (ELUT) Q4 2024 earnings call?

The live and archived webcast will be available on the 'Investors' section of Elutia's website at http://investors.elutia.com/.